Orion Integrated Biosciences Inc. is becoming a world leader in the development of identification systems using motif fingerprints and genomic signatures and the translation of this proprietary information into a new generation of pathogen detection platforms, vaccines and antimicrobials. Our balanced R&D pipeline is enhanced by key and close partnerships with researchers at the Department of Defense, National Laboratories, Universities and other private institutions which allow our corporation to access high level biosecurity facilities, animal models and select agent pathogens while working with these customers to improve the quality of our products and respond early to their needs. Our collaborators include:
The Defence Science and Technology Laboratory (Dstl) ensures that innovative science and technology contribute to the defence and security of the UK.
IF – EBOLA
IF-EBOLa has been strategically designed to efficiently respond to critical needs required to control the current EBOV outbreak from spreading. The work will involve two of the main EVD outbreak sites, Sierra Leone and Guinea. MDs, public health authorities and virus experts working on site, under ethical regulatory rules, will extend their collaboration to companies and institution to form…
Exelis-Harris provides advanced, technology-based solutions that solve government and commercial customers’ mission critical challenges. The company has approximately $8 billion in annual revenue and about 23,000 employees – including 9,000 engineers and scientists – supporting customers in more than 125 countries.
MBCOI’s mission is to accelerate the commercialization of innovative technologies by uniting stakeholders in marine research both domestically and internationally.
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
UNC’s research program is balanced between applied environmental microbiology research and the study of marine microbial food webs
DTRA’s support the ongoing revolution in the life sciences by seeking to ensure that resulting discoveries and their applications, used solely for peaceful and beneficial purposes, are globally available.
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) conducts research to develop strategies, products, information, procedures, and training programs for medical defense against biological warfare threats and naturally occurring infectious diseases that require special containment.
DHS’ vision of homeland security is to ensure a homeland that is safe, secure, and resilient against terrorism and other hazards
Together AECOM and URS are one of the world’s premier, fully integrated infrastructure and support services firms. We design, build, finance, and operate infrastructure assets in more than 150 countries around the world—across a broad range of markets including transportation, facilities, environmental, energy, water, and government services.
CEEZAD’s seeks to enhance the capability of the US Department of Homeland Security (DHS) by developing “state of the art” countermeasures for high priority emerging and zoonotic animal diseases.